Acme United Corporation – FDA 483, Mar 28, 2025
Acme United Corporation received a Form 483 citing significant deficiencies in quality control, manufacturing processes, and facility maintenance. The firm failed to conduct thorough investigations into out-of-specification results, lacked adequate testing and validation for its drug products and equipment, and demonstrated poor control over computer systems and equipment identification. These issues indicate a systemic breakdown in ensuring product quality and compliance with cGMP regulations.
ID · 096890ef-52ee-4ac9-a7ee-268eb5eee4f9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.